Mineralys Therapeutics (MLYS) EBIT (2022 - 2026)
Mineralys Therapeutics (MLYS) posted EBIT of -$60.09 million for Q3 2026, compared with -$41.13 million a year earlier.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) EBIT (2022 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBIT at Mineralys Therapeutics was -$389.75 million; for FY2025, it came in at -$170.6 million.
- In prior years, Mineralys Therapeutics' EBIT was -$192.4 million in FY2024, -$84.66 million in FY2023 and -$31.48 million in FY2022.
- Quarterly EBIT has run from a low of -$246.04 million in Q2 2026 to a high of -$6.48 million in Q2 2022 over five years.
- According to Business Quant data, EBIT for the three prior quarters was -$246.04 million (Q2 2026), -$45.34 million (Q1 2026) and -$38.28 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 12.79 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.59 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Mineralys Therapeutics | 1.42 Bn | -1.17 Bn | - | -60.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -60.09 Mn |
| Jun 30, 2026 | -246.04 Mn |
| Mar 31, 2026 | -45.34 Mn |
| Dec 31, 2025 | -38.28 Mn |
| Sep 30, 2025 | -41.13 Mn |
| Jun 30, 2025 | -46.75 Mn |
| Mar 31, 2025 | -44.45 Mn |
| Dec 31, 2024 | -51.77 Mn |
| Sep 30, 2024 | -60.11 Mn |
| Jun 30, 2024 | -45.17 Mn |
| Mar 31, 2024 | -35.36 Mn |
| Dec 31, 2023 | -27.71 Mn |
| Sep 30, 2023 | -26.27 Mn |
| Jun 30, 2023 | -15.74 Mn |
| Mar 31, 2023 | -14.94 Mn |
| Dec 31, 2022 | -10.01 Mn |
| Sep 30, 2022 | -7.42 Mn |
| Jun 30, 2022 | -6.48 Mn |
| Mar 31, 2022 | -7.57 Mn |
API Access
Mineralys Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();